AU2011220326B2 - Method of treatment or prevention of hair loss or for the enhancement of hair growth - Google Patents

Method of treatment or prevention of hair loss or for the enhancement of hair growth Download PDF

Info

Publication number
AU2011220326B2
AU2011220326B2 AU2011220326A AU2011220326A AU2011220326B2 AU 2011220326 B2 AU2011220326 B2 AU 2011220326B2 AU 2011220326 A AU2011220326 A AU 2011220326A AU 2011220326 A AU2011220326 A AU 2011220326A AU 2011220326 B2 AU2011220326 B2 AU 2011220326B2
Authority
AU
Australia
Prior art keywords
hair
alopecia
midkine
subject
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011220326A
Other languages
English (en)
Other versions
AU2011220326A1 (en
Inventor
Maria Halasz
Darren Jones
Sadatoshi Sakuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advangen International Pty Ltd
Original Assignee
Advangen International Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010900771A external-priority patent/AU2010900771A0/en
Application filed by Advangen International Pty Ltd filed Critical Advangen International Pty Ltd
Priority to AU2011220326A priority Critical patent/AU2011220326B2/en
Publication of AU2011220326A1 publication Critical patent/AU2011220326A1/en
Application granted granted Critical
Publication of AU2011220326B2 publication Critical patent/AU2011220326B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
AU2011220326A 2010-02-24 2011-02-23 Method of treatment or prevention of hair loss or for the enhancement of hair growth Ceased AU2011220326B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2011220326A AU2011220326B2 (en) 2010-02-24 2011-02-23 Method of treatment or prevention of hair loss or for the enhancement of hair growth

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2010900771 2010-02-24
AU2010900771A AU2010900771A0 (en) 2010-02-24 Method of treatment or prevention of hair loss or for the enhancement of hair growth
PCT/AU2011/000194 WO2011103624A1 (en) 2010-02-24 2011-02-23 Method of treatment or prevention of hair loss or for the enhancement of hair growth
AU2011220326A AU2011220326B2 (en) 2010-02-24 2011-02-23 Method of treatment or prevention of hair loss or for the enhancement of hair growth

Publications (2)

Publication Number Publication Date
AU2011220326A1 AU2011220326A1 (en) 2012-08-23
AU2011220326B2 true AU2011220326B2 (en) 2014-11-20

Family

ID=44506072

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011220326A Ceased AU2011220326B2 (en) 2010-02-24 2011-02-23 Method of treatment or prevention of hair loss or for the enhancement of hair growth

Country Status (8)

Country Link
US (2) US20130067604A1 (enExample)
EP (1) EP2538963B8 (enExample)
JP (1) JP5850862B2 (enExample)
KR (2) KR101953742B1 (enExample)
CN (2) CN106075398A (enExample)
AU (1) AU2011220326B2 (enExample)
GB (1) GB2490854B (enExample)
WO (1) WO2011103624A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2867901A1 (en) * 2012-03-21 2013-09-26 The Trustees Of The University Of Pennsylvania Compositions and methods for regulating hair growth
KR101921246B1 (ko) * 2017-01-04 2018-11-22 주식회사 베스트앤퍼스트바이오텍 탈모 방지 및 양모를 위한 헤어 필러 조성물 및 그 제조 방법
FR3061656B1 (fr) * 2017-01-09 2019-05-24 Societe Industrielle Limousine D'application Biologique Hydrolysat de pichia minuta et utilisation cosmetique pour lutter contre la chute des cheveux et favoriser leur repousse
CN108014328A (zh) * 2017-12-19 2018-05-11 吴广印 一种预防脱发、促进生发物质的配方及其制备方法
CN111991413B (zh) * 2020-09-18 2021-10-08 中国人民解放军陆军特色医学中心 一种预防脱发或促进毛发生长的多糖组合物及其制剂和应用
US20240269240A1 (en) * 2023-02-15 2024-08-15 Blue Blood Biotech Corporation Compositions and methods for treating hair loss or facilitating hair growth

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030202960A1 (en) * 1998-04-17 2003-10-30 Colley Kenneth J. Therapeutic angiogenic factors and methods for their use
WO2005001044A2 (en) * 2003-05-29 2005-01-06 Angiogenix, Inc. Compositions related to pleiotrophin methods and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
JPH04224522A (ja) * 1990-04-27 1992-08-13 Merck & Co Inc 繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
JPH05124935A (ja) * 1991-10-31 1993-05-21 Kao Corp 毛成長促進剤
US5767152A (en) * 1995-05-04 1998-06-16 Nielsen; Thor Bagger Composition and methods for stimulating hair growth
JPH09157183A (ja) * 1995-12-07 1997-06-17 Meiji Milk Prod Co Ltd 皮膚外用剤
JPH10251158A (ja) * 1997-03-06 1998-09-22 Noevir Co Ltd 皮膚外用剤
JP3667027B2 (ja) * 1997-03-06 2005-07-06 株式会社ノエビア 皮膚外用剤
CN1331155A (zh) * 2000-06-28 2002-01-16 上海博德基因开发有限公司 一种新的多肽——人肝素结合生长因子受体K－ram9.13和编码这种多肽的多核苷酸
US20030215412A1 (en) * 2000-07-21 2003-11-20 Essentia Biosystems, Inc. Induction of hair growth with vascular endothelial growth factor
WO2003072049A2 (en) * 2002-02-21 2003-09-04 Essentia Biosystems, Inc. Induction of hair growth with vascular endothelial growth factor
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
EP1715869A1 (en) * 2004-02-12 2006-11-02 Warner-Lambert Company LLC Method of stimulating hair growth

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030202960A1 (en) * 1998-04-17 2003-10-30 Colley Kenneth J. Therapeutic angiogenic factors and methods for their use
WO2005001044A2 (en) * 2003-05-29 2005-01-06 Angiogenix, Inc. Compositions related to pleiotrophin methods and uses thereof

Also Published As

Publication number Publication date
JP2013520447A (ja) 2013-06-06
AU2011220326A1 (en) 2012-08-23
KR20180056814A (ko) 2018-05-29
CN106075398A (zh) 2016-11-09
GB2490854A (en) 2012-11-14
EP2538963A1 (en) 2013-01-02
GB2490854B (en) 2014-07-16
KR20140017416A (ko) 2014-02-11
US20150044139A1 (en) 2015-02-12
US20130067604A1 (en) 2013-03-14
CN102791284A (zh) 2012-11-21
KR101953742B1 (ko) 2019-03-04
EP2538963B8 (en) 2017-08-02
EP2538963A4 (en) 2013-09-11
EP2538963B1 (en) 2017-05-17
WO2011103624A1 (en) 2011-09-01
US9622955B2 (en) 2017-04-18
GB201216817D0 (en) 2012-11-07
JP5850862B2 (ja) 2016-02-03

Similar Documents

Publication Publication Date Title
US9622955B2 (en) Method of treatment or prevention of hair loss or for the enhancement of hair growth
JP4229842B2 (ja) Ｌ−アルギニンオリゴマーを含む化粧品処方
US20190091494A1 (en) Peptides for hair growth
US12318429B2 (en) Peptide for preventing or treating hair loss, and use thereof
JP5685315B2 (ja) ニコチン酸アデニンディヌクレオチドリン酸又はその誘導体を含む薬学又は化粧料組成物
JP2025061604A (ja) タンパク質糖化抑制剤
JP5216414B2 (ja) 育毛剤
CN107693780B (zh) 用于预防或治疗脱发的药学组合物
KR102000217B1 (ko) Cxcl1 단백질 및 미녹시딜을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물
JP5166116B2 (ja) 育毛剤
CN114306602B (zh) 靶向tert在调节皮肤及毛发色素中的应用
HK1218246A1 (zh) 显示出脱发预防活性和毛发生长刺激活性的包含由朝鲜刺五加和白缘文殊兰组成的组合草药的提取物的组合物
KR102890438B1 (ko) 탈모 증상 완화능을 갖는 두피 유래 펩타이드
HK1178788A (en) Method of treatment or prevention of hair loss or for the enhancement of hair growth
JP6787754B2 (ja) メラニン分解促進剤
TW201429501A (zh) 促進毛髮生長之組合物
CN114007578A (zh) 毛发增长及头皮制剂
JP2007277134A (ja) インターロイキン−６産生抑制剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired